Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01764165 · ClinicalTrials.gov registry record · NA

Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD)

A NA study of COPD, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT01764165: Completed NA study of COPD, sponsored by Johns Hopkins University.

NCT01764165 is a NA study of COPD that has completed, run by Johns Hopkins University. The registered enrollment target is 52 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01764165, a NA study of COPD, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

This research is being conducted to examine the effects of nasal insufflation of warm and humidified air through a small nasal cannula on sleep, breathing pulmonary function, and daytime exercise capability.

Primary Outcome

Lung function declines over the course of the night. We hypothesize that delivering warm and humidified air at a rate of 20 L/min over the entire night improves morning FEV1 compared to oxygen.

Conditions Studied

Interventions

  • OTHER Oxygen
  • OTHER High flow of room air

Study Locations (1)

Maryland

  • Johns Hopkins - Baltimore

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2012-08
Est. Completion 2016-10
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT01764165 record still lists

NCT01764165 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (98% lower).

The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 2 interventions - of which Oxygen is the first listed.

NCT01764165 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01764165 about?

NCT01764165 is a clinical study titled "Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD)". This research is being conducted to examine the effects of nasal insufflation of warm and humidified air through a small nasal cannula on sleep, breathing pulmonary function, and daytime exercise capability.

What is the current status of trial NCT01764165?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2012-08. Estimated completion is 2016-10.

What conditions does trial NCT01764165 study?

This clinical trial studies the following conditions: COPD.

What interventions are being tested in trial NCT01764165?

The interventions under investigation include: Oxygen (OTHER), High flow of room air (OTHER).

Who is sponsoring clinical trial NCT01764165?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01764165 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01764165's enrollment target sits among peer trials

52 51st of 85 higher than 35 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01764165, the US trial registry maintained by the National Library of Medicine. NCT01764165 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.